AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ELEVRA LITHIUM LTD

8.250

-0.050-0.60%

Volume:1.51M

Turnover:12.58M

Market Cap:1.60B

PE:-4.91

High:8.500

Open:8.100

Low:7.970

Close:8.300

52wk High:14.060

52wk Low:2.700

Shares:194.02M

Float Shares:166.89M

Volume Ratio:1.05

T/O Rate:0.91%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.679

EPS(LYR):-5.720

ROE:8.41%

ROA:-0.59%

PB:1.58

PE(LYR):-1.44

Loading ...

Overview Company News Filings

Elevance Health (ELV) Is Up 6.7% After Raising 2026 EPS Outlook And Boosting Capital Returns – Has The Bull Case Changed?

Simply Wall St.

Assessing Elevra Lithium (ASX:ELV) Valuation After Record Quarterly Revenue And Operational Improvements

Simply Wall St.

Elevance Health's Tone on 2027 Commercial Pipeline 'Constructive,' RBC Says

MT Newswires Live

BUZZ-Australia's Elevra Lithium hits over 2-year high on upbeat quarterly revenue

Elevra Lithium Posts Higher Spodumene Concentrate Production in March Quarter; Shares Reach Over Two-Year High

MT Newswires Live

BRIEF-Elevra Lithium Posts Qtrly Revenue $81 Million For North American Lithium

Stock Track | Elevra Lithium Soars 5.17% Intraday on Strong Quarterly Results and Operational Improvements

Elevra Lithium Ltd - Elevra Has Only Limited Exposure to Liquid Fuel Prices and Reduced Fuel Availability for North American Lithium

THOMSON REUTERS

Elevra Lithium Ltd - Qtrly North American Lithium Spodumene Concentrate Production up 7% Qoq to 47,332 Dmt at 5.0% Grade

THOMSON REUTERS

Elevra Lithium Ltd: Reaffirms FY26 Production Guidance of 180,000–190,000 Dmt, Sales Guidance of 170,000– 190,000 Dmt

THOMSON REUTERS

GUIDANCE: (ELV) Elevance Health Expects 2026 Adjusted EPS of At Least $26.75, vs. FactSet Est of $25.77

MT Newswires Live

Assessing Elevance Health (ELV) Valuation As Shares Show Short Term Momentum But Longer Term Weakness

Simply Wall St.

Elevra Lithium to release March-quarter activities report, host investor webcast

A Look At Elevance Health (ELV) Valuation After Earnings Beat EPS But Missed Revenue And Membership Declines

Simply Wall St.

Elevra Lithium Says BNY Mellon Cuts Stake

MT Newswires Live

President & COO of Canada Of Elevra Lithium Sold 33% Of Their Shares

Simply Wall St.

Is It Time To Reassess Elevance Health (ELV) After A 26% One-Year Share Price Fall

Simply Wall St.

A Look At Elevance Health (ELV) Valuation After Strong Q4 Results Dividend Hike And Leadership Changes

Simply Wall St.

Is It Time To Reassess Elevance Health (ELV) After A 33% One‑Year Share Price Slide

Simply Wall St.

Morella Completes Reverse Circulation Drilling at Western Australia Rubidium-Lithium Project; Shares Jump 7%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/ELV.AU/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ELV.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ELV.AU\",,,,,undefined,":{"symbol":"ELV.AU","market":"AU","secType":"STK","nameCN":"ELEVRA LITHIUM LTD","latestPrice":8.25,"timestamp":1788156720000,"preClose":8.3,"halted":0,"volume":1513186,"delay":0,"changeRate":-0.006024096385542254,"nameEN":"ELEVRA LITHIUM LTD","floatShares":166890429,"shares":194016000,"eps":-1.6791675687000245,"marketStatus":"Closed","change":-0.05,"latestTime":"08-31 16:12:00 AEST","open":8.1,"high":8.5,"low":7.97,"amount":12575709,"amplitude":0.063855,"askPrice":8.39,"askSize":2000,"bidPrice":8.24,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-1.6791675687000245,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":8.3,"openAndCloseTimeList":[[1788134400000,1788156000000]],"volumeRatio":1.052339,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ELV.AU","preClose":8.3,"auctionPrice":8.25,"auctionVolume":374171,"auctionTime":1788156606440,"referencePrice":8.25,"referenceTime":1788166800653,"auction":3,"marketStatus":"盘后竞价","timestamp":1788156606440}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ELV.AU\",,,,,undefined,":{"symbol":"ELV.AU","floatShares":166890429,"roa":"-0.59%","roe":"8.41%","lyrEps":-5.719606,"volumeRatio":1.052339,"shares":194016000,"dividePrice":0,"high":8.5,"amplitude":0.063855,"preClose":8.3,"low":7.97,"week52Low":2.7,"pbRate":"1.58","psRate":"5.67","week52High":14.06,"institutionHeld":0,"latestPrice":8.25,"committee":-0.6,"eps":-1.6791675687000245,"divideRate":0,"volume":1513186,"delay":0,"ttmEps":-1.6791675687000245,"open":8.1,"prevYearClose":8.04,"prevWeekClose":8.3,"prevMonthClose":7.46,"prevQuarterClose":9.6,"fiveDayClose":9.63,"twentyDayClose":7.23,"sixtyDayClose":11.03,"dividendPayoutRate":0,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ELV.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"ELV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787875200000,"name":null,"time":"","dateTimestamp":1787839200000,"actualEps":null},{"date":"2026-07-28","symbol":"ELV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1785196800000,"name":null,"time":"","dateTimestamp":1785160800000,"actualEps":null},{"date":"2026-04-23","symbol":"ELV.AU","type":"earning","reportTimeType":"pre","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776902400000,"name":null,"time":"Pre-MKt","dateTimestamp":1776866400000,"actualEps":null},{"date":"2026-02-24","symbol":"ELV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771887600000,"name":null,"time":"","dateTimestamp":1771851600000,"actualEps":null},{"date":"2026-01-28","symbol":"ELV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1769554800000,"name":null,"time":"","dateTimestamp":1769518800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ELV.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ELV.AU\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2630802405","title":"Elevance Health (ELV) Is Up 6.7% After Raising 2026 EPS Outlook And Boosting Capital Returns – Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2630802405","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630802405?lang=en_us&edition=fundamental","pubTime":"2026-04-26 05:09","pubTimestamp":1777151358,"startTime":"0","endTime":"0","summary":"Earlier this week, Elevance Health reported first-quarter 2026 results with revenue of US$50.18 billion and net income of US$1.76 billion, while also declaring a second-quarter dividend of US$1.72 per share and updating full-year 2026 diluted EPS guidance to at least US$19.85.\nBeneath the headline numbers, the quarter featured earnings that exceeded analyst expectations, a higher adjusted EPS outlook, and ongoing support from share repurchases that reduced the share count by 3,700,000 in the...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/elevance-health-elv-is-up-67-after-raising-2026-eps-outlook","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/elevance-health-elv-is-up-67-after-raising-2026-eps-outlook","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ELV","ELV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630721870","title":"Assessing Elevra Lithium (ASX:ELV) Valuation After Record Quarterly Revenue And Operational Improvements","url":"https://stock-news.laohu8.com/highlight/detail?id=2630721870","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630721870?lang=en_us&edition=fundamental","pubTime":"2026-04-25 17:18","pubTimestamp":1777108720,"startTime":"0","endTime":"0","summary":"Elevra Lithium (ASX:ELV) is back in focus after its March quarterly update highlighted improved execution at the North American Lithium operation, high plant utilization, stronger lithium recovery and record quarterly revenue of $81 million.\nSee our latest analysis for Elevra Lithium.\nThe share price has reacted strongly to the March update and the upcoming Q3 2026 results. A 1 month share price return of 52.02% has helped lift the 1 year total shareholder return to 322.46%, although the 3...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-elv/elevra-lithium-shares/news/assessing-elevra-lithium-asxelv-valuation-after-record-quart","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-elv/elevra-lithium-shares/news/assessing-elevra-lithium-asxelv-valuation-after-record-quart","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LIT","SETM","ELV","ELV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629859449","title":"Elevance Health's Tone on 2027 Commercial Pipeline 'Constructive,' RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2629859449","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629859449?lang=en_us&edition=fundamental","pubTime":"2026-04-24 00:20","pubTimestamp":1776961231,"startTime":"0","endTime":"0","summary":"Elevance Health's  tone on the 2027 commercial pipeline was \"constructive,\" RBC Capital Markets said in a note emailed Thursday.Analysts said that the company's Q1 core performance beat expectations, supported by favorable Medicare claims experience, a better-than-anticipated adjusted operating expense ratio, and early traction with Medicaid cost actions.RBC said it is still cautious on the stock as Elevance navigates an elevated Medicaid cost environment, ongoing Affordable Care Act risk-pool uncertainty, and 2027 Medicare Advantage rates, which continue to fall behind trend.Analysts lowered their Q2 adjusted earnings per share estimate for the company to $6.14 from $6.64. Analysts polled by FactSet expect $6.38.RBC, however, increased the full-year 2026 adjusted earnings per share estimate to $26.82 from $25.55. Analysts surveyed by FactSet expect $26.43.Analysts maintained a sector perform rating on the stock and a $358 price target.Price: 343.85, Change: +15.65, Percent Change: +4.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1983299246.USD","ELV.AU","BK4154","ELV","LU0048573561.USD","LU0345770308.USD","LU0648001328.SGD","LU0266013472.USD","LU0106261372.USD","LU0130517989.USD","LU0068578508.USD","LU2430703178.SGD","LU0058720904.USD","LU1280957306.USD","LU1670627923.USD","LU0345770993.USD","SG9999003800.SGD","LU1023059063.AUD","LU2237957902.USD","SG9999001077.SGD","LU2237957811.SGD","LU0980610538.SGD","BK7095","LU0477156953.USD","LU2430703251.USD","LU0211331839.USD","SG9999004303.SGD","LU0882574055.USD","LU2505996509.AUD","LU2592432038.USD","LU2505996681.GBP","BK4585","SG9999011175.SGD","LU0225283273.USD","LU0314104364.USD","LU0640476718.USD","LU0208291251.USD","LU0289739699.SGD","LU0122379950.USD","LU0314106906.USD","LU1489326972.SGD","LU2362540622.SGD","LU0006306889.USD","LU1506573853.SGD","LU1548497426.USD","LU2357305700.SGD","LU0557290698.USD","LU1720051108.HKD","LU0187121727.USD","LU0070302665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629003949","title":"BUZZ-Australia's Elevra Lithium hits over 2-year high on upbeat quarterly revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2629003949","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629003949?lang=en_us&edition=fundamental","pubTime":"2026-04-23 11:06","pubTimestamp":1776913615,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Elevra Lithium hits over 2-year high on upbeat quarterly revenue** Shares of Elevra Lithium ELV.AX rise as much as 6.2% to A$11.1, their highest level since December 20, 2023** Lithium producer posts quarterly revenue of $81 million, up 22% quarter on quarter  ** Reaffirms FY26 production guidance of 180,000–190,000 dmt, sales guidance of 170,000–190,000 dmt ** Stock is up 34.5% YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nL6N41608L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7095","ELV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629257070","title":"Elevra Lithium Posts Higher Spodumene Concentrate Production in March Quarter; Shares Reach Over Two-Year High","url":"https://stock-news.laohu8.com/highlight/detail?id=2629257070","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629257070?lang=en_us&edition=fundamental","pubTime":"2026-04-23 10:01","pubTimestamp":1776909705,"startTime":"0","endTime":"0","summary":"Elevra Lithium's  spodumene concentrate production from its North American Lithium operation in Canada rose to 47,332 dry metric tonnes  in the March quarter from 43,261 dmt during the same period last year, according to a Thursday filing with the Australian bourse.Spodumene concentrate sales were 55,526 dmt at an average realized selling price of $1,453 per dmt, up from 27,030 dmt at an average realized selling price of $710 per dmt in March 2025, the filing said.The company reaffirmed its fiscal 2026 production guidance of 180,000 dmt to 190,000 dmt and sales guidance of 170,000 to 190,000 dmt, subject to the fulfillment of the shipping schedule, per the filing.Shares rose about 2% in recent Thursday trade and earlier reached their highest since November 2023.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","ELVR","LIT","BK4585","BK4168","SETM","ELV.AU","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629708370","title":"BRIEF-Elevra Lithium Posts Qtrly Revenue $81 Million For North American Lithium","url":"https://stock-news.laohu8.com/highlight/detail?id=2629708370","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629708370?lang=en_us&edition=fundamental","pubTime":"2026-04-23 09:33","pubTimestamp":1776908035,"startTime":"0","endTime":"0","summary":"BRIEF-Elevra Lithium Posts Qtrly Revenue $81 Million For North American LithiumApril 23  - Elevra Lithium Ltd ELV.AX:QTRLY REVENUE RISES 22% TO $81 MILLION FOR NORTH AMERICAN LITHIUMREAFFIRMS FY26 PRODUCTION GUIDANCE OF 180,000–190,000 DMT, SALES GUIDANCE OF 170,000–  190,000 DMTQTRLY NORTH AMERICAN LITHIUM SPODUMENE CONCENTRATE PRODUCTION UP 7% QOQ TO 47,332 DMT AT 5.0% GRADEELEVRA HAS ONLY LIMITED EXPOSURE TO LIQUID FUEL PRICES AND REDUCED FUEL AVAILABILITY FOR NORTH AMERICAN LITHIUMFurther company coverage: ELV.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nFWN4150X6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7095","ELV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135209972","title":"Stock Track | Elevra Lithium Soars 5.17% Intraday on Strong Quarterly Results and Operational Improvements","url":"https://stock-news.laohu8.com/highlight/detail?id=1135209972","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135209972?lang=en_us&edition=fundamental","pubTime":"2026-04-23 08:33","pubTimestamp":1776904387,"startTime":"0","endTime":"0","summary":"ELEVRA LITHIUM LTD's stock experienced a significant surge of 5.17% during intraday trading on Thursday. The sharp upward movement reflects strong investor sentiment following the release of the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ELV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629951076","title":"Elevra Lithium Ltd - Elevra Has Only Limited Exposure to Liquid Fuel Prices and Reduced Fuel Availability for North American Lithium","url":"https://stock-news.laohu8.com/highlight/detail?id=2629951076","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629951076?lang=en_us&edition=fundamental","pubTime":"2026-04-23 06:12","pubTimestamp":1776895921,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nFWN4150X6:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","ELV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629076955","title":"Elevra Lithium Ltd - Qtrly North American Lithium Spodumene Concentrate Production up 7% Qoq to 47,332 Dmt at 5.0% Grade","url":"https://stock-news.laohu8.com/highlight/detail?id=2629076955","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629076955?lang=en_us&edition=fundamental","pubTime":"2026-04-23 06:12","pubTimestamp":1776895921,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nFWN4150X6:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","ELV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629076953","title":"Elevra Lithium Ltd: Reaffirms FY26 Production Guidance of 180,000–190,000 Dmt, Sales Guidance of 170,000–  190,000 Dmt","url":"https://stock-news.laohu8.com/highlight/detail?id=2629076953","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629076953?lang=en_us&edition=fundamental","pubTime":"2026-04-23 06:12","pubTimestamp":1776895921,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nFWN4150X6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELV.AU","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629201476","title":"GUIDANCE: (ELV) Elevance Health Expects 2026 Adjusted EPS of At Least $26.75, vs. FactSet Est of $25.77","url":"https://stock-news.laohu8.com/highlight/detail?id=2629201476","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629201476?lang=en_us&edition=fundamental","pubTime":"2026-04-22 18:04","pubTimestamp":1776852293,"startTime":"0","endTime":"0","summary":"GUIDANCE: (ELV) Elevance Health Expects 2026 Adjusted EPS of At Least $26.75, vs. FactSet Est of $25.77","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ELV","ELV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629004407","title":"Assessing Elevance Health (ELV) Valuation As Shares Show Short Term Momentum But Longer Term Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=2629004407","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629004407?lang=en_us&edition=fundamental","pubTime":"2026-04-21 13:05","pubTimestamp":1776747911,"startTime":"0","endTime":"0","summary":"Elevance Health stock snapshot and recent moves\nElevance Health (ELV) has been trading around US$319.36, with a return of about 9.6% over the past month but a return of roughly 13% decline over the past 3 months.\nSee our latest analysis for Elevance Health.\nShort term share price momentum has picked up, with a 1 month share price return of 9.6%. However, this follows a 3 month share price return decline of 13% and a 1 year total shareholder return decline of 19.8%, which suggests sentiment...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/assessing-elevance-health-elv-valuation-as-shares-show-short","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/assessing-elevance-health-elv-valuation-as-shares-show-short","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2362541273.HKD","LU2505996509.AUD","LU2505996681.GBP","LU1670627923.USD","ELV.AU","LU0130102774.USD","LU1023059063.AUD","LU0477156953.USD","LU0225283273.USD","LU0878866978.SGD","LU0114720955.EUR","LU0957791311.USD","LU0006306889.USD","LU0048573561.USD","LU1548497426.USD","LU0266013472.USD","LU2362541513.USD","LU2430703095.HKD","LU0068578508.USD","BK7095","LU0234570918.USD","LU0345770308.USD","LU0320765489.SGD","LU0058720904.USD","LU0433182093.SGD","LU0251131958.USD","LU1057294990.SGD","LU2237957902.USD","LU0640476718.USD","LU1815333072.USD","LU2362540622.SGD","LU0980610538.SGD","LU1983299246.USD","SGXZ23171101.USD","ELV","LU0251142724.SGD","LU0211331839.USD","LU0208291251.USD","LU1720051017.SGD","LU0345770993.USD","LU0170899867.USD","LU2430703178.SGD","LU0070302665.USD","LU1280957306.USD","LU0648001328.SGD","LU1506573853.SGD","LU2237957811.SGD","LU2430703251.USD","LU0061474960.USD","LU1670628061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627230875","title":"Elevra Lithium to release March-quarter activities report, host investor webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2627230875","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627230875?lang=en_us&edition=fundamental","pubTime":"2026-04-16 04:16","pubTimestamp":1776284205,"startTime":"0","endTime":"0","summary":"Elevra Lithium scheduled release of March 2026 Quarterly Activities Report for April 23, 2026.Investor webcast set for April 23, 2026 at 9:30 a.m. AEST, or April 22, 2026 at 7:30 p.m. ET.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL2qDnmt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","SG9999014039.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","ELV.AU","BK7504","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","SG9999014013.SGD","SG9999014021.USD","BK4112","IE00BN0W2V16.EUR","CXO.AU","LU2210149790.SGD","IE00BKPKM429.USD","BK7095","NDAQ","LU2210150020.SGD","LU2095319765.USD","SG9999014005.SGD","BK4585","IE00B3QW5Z07.USD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627671344","title":"A Look At Elevance Health (ELV) Valuation After Earnings Beat EPS But Missed Revenue And Membership Declines","url":"https://stock-news.laohu8.com/highlight/detail?id=2627671344","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627671344?lang=en_us&edition=fundamental","pubTime":"2026-04-14 08:43","pubTimestamp":1776127427,"startTime":"0","endTime":"0","summary":"Elevance Health (ELV) is in focus after reporting earnings with adjusted EPS above expectations but revenue below forecasts, while also disclosing declines in Medicaid and Medicare Advantage membership.\nSee our latest analysis for Elevance Health.\nThe stock has reacted to these mixed signals with a 1-day share price return of 1.46% and a 7-day share price return of 4.45%. However, the 1-year total shareholder return of 26.83% and 3-year total shareholder return of 31.50% point to weaker...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/a-look-at-elevance-health-elv-valuation-after-earnings-beat","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/a-look-at-elevance-health-elv-valuation-after-earnings-beat","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ELV.AU","ELV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627819474","title":"Elevra Lithium Says BNY Mellon Cuts Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2627819474","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627819474?lang=en_us&edition=fundamental","pubTime":"2026-04-13 13:44","pubTimestamp":1776059071,"startTime":"0","endTime":"0","summary":"Elevra Lithium  said The Bank of New York Mellon Corporation and its group entities have reduced their stake in the company on April 9 to 22.32% or 37.8 million shares from 23.33% or 39.5 million shares, according to a Monday Australian bourse filing.The company's shares fell 2% in recent Monday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ELVR","BK4585","BK4168","LIT","SETM","ELV.AU","BK4588","BNY","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626151477","title":"President & COO of Canada Of Elevra Lithium Sold 33% Of Their Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2626151477","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626151477?lang=en_us&edition=fundamental","pubTime":"2026-04-10 08:26","pubTimestamp":1775780818,"startTime":"0","endTime":"0","summary":"We'd be surprised if Elevra Lithium Limited ( ASX:ELV ) shareholders haven't noticed that the President & COO of...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-elv/elevra-lithium-shares/news/president-coo-of-canada-of-elevra-lithium-sold-33-of-their-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-elv/elevra-lithium-shares/news/president-coo-of-canada-of-elevra-lithium-sold-33-of-their-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1992135399.USD","LU2211815571.USD","BK4585","BK4168","LU2272731600.USD","ELVR","COO","LU1992135472.HKD","BK4198","GB00BDT5M118.USD","LIT","LU2272731782.SGD","SETM","ELV.AU","BK7095","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626922175","title":"Is It Time To Reassess Elevance Health (ELV) After A 26% One-Year Share Price Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2626922175","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626922175?lang=en_us&edition=fundamental","pubTime":"2026-04-09 04:22","pubTimestamp":1775679777,"startTime":"0","endTime":"0","summary":"Wondering if Elevance Health at around US$311 a share still offers value, or if the best entry point has passed? This article walks through the key numbers that matter for you.\nThe stock has returned 6.5% over the last week and 7.7% over the last month, yet it remains 12.0% lower year to date and 26.1% lower over the last year, which sets an interesting backdrop for thinking about risk and value.\nRecent attention on Elevance Health has focused on its position in the US healthcare sector and...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/is-it-time-to-reassess-elevance-health-elv-after-a-26-one-ye","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/is-it-time-to-reassess-elevance-health-elv-after-a-26-one-ye","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0314106906.USD","LU2362541273.HKD","LU1720051017.SGD","LU2357305700.SGD","LU0320765489.SGD","LU0225283273.USD","LU2362540622.SGD","LU1720051108.HKD","LU1280957306.USD","LU0742534661.SGD","LU0130102774.USD","LU1201861249.SGD","LU0648001328.SGD","ELV.AU","FCF","LU2430703178.SGD","LU0061474960.USD","LU2505996509.AUD","LU1489326972.SGD","LU0234570918.USD","LU0122379950.USD","LU2592432038.USD","LU1548497426.USD","LU0878866978.SGD","LU0477156953.USD","LU0130517989.USD","LU0211331839.USD","BK4585","BK4154","LU0187121727.USD","ELV","LU0557290698.USD","LU1057294990.SGD","LU1506573853.SGD","LU0170899867.USD","LU0251142724.SGD","LU2505996681.GBP","LU0640476718.USD","LU1983299246.USD","LU0980610538.SGD","LU1023059063.AUD","LU1670628061.USD","SGXZ23171101.USD","LU2244417387.USD","LU0433182093.SGD","LU0882574055.USD","DCF","LU0006306889.USD","LU2362541513.USD","LU0106261372.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625648776","title":"A Look At Elevance Health (ELV) Valuation After Strong Q4 Results Dividend Hike And Leadership Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2625648776","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625648776?lang=en_us&edition=fundamental","pubTime":"2026-04-05 10:23","pubTimestamp":1775355789,"startTime":"0","endTime":"0","summary":"Elevance Health (ELV) is back in focus after strong fourth quarter earnings, a higher dividend, updated full year guidance, and a flurry of senior appointments across its Health Benefits and Carelon units.\nSee our latest analysis for Elevance Health.\nThe recent leadership reshuffle, strong fourth quarter results, higher dividend, and updated guidance have helped the share price rebound, with a 7 day share price return of 5.01% and a 30 day share price return of 4.98%. However, the 1 year...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/a-look-at-elevance-health-elv-valuation-after-strong-q4-resu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/a-look-at-elevance-health-elv-valuation-after-strong-q4-resu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1670628061.USD","SG9999003800.SGD","LU0006306889.USD","LU2430703178.SGD","LU0477156953.USD","LU2592432038.USD","LU2108987350.USD","LU0980610538.SGD","LU2430703251.USD","LU0187121727.USD","LU0061474960.USD","LU0068578508.USD","LU0130102774.USD","LU0878866978.SGD","LU2505996509.AUD","LU0314106906.USD","LU2362541273.HKD","LU2237957811.SGD","LU0048573561.USD","LU0225283273.USD","LU0289739699.SGD","LU1548497426.USD","LU0211331839.USD","LU1720051017.SGD","LU0070302665.USD","LU2362541513.USD","LU0251131958.USD","LU0266013472.USD","LU1023059063.AUD","LU1057294990.SGD","LU1720051108.HKD","ELV.AU","LU0648001328.SGD","LU1201861249.SGD","LU2505996681.GBP","LU0130517989.USD","LU0170899867.USD","LU0957791311.USD","BK4154","BK4585","BK4588","ELV","LU0106261372.USD","LU0234570918.USD","LU0320765489.SGD","LU0433182093.SGD","LU1506573853.SGD","LU0640476718.USD","LU0882574055.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623309535","title":"Is It Time To Reassess Elevance Health (ELV) After A 33% One‑Year Share Price Slide","url":"https://stock-news.laohu8.com/highlight/detail?id=2623309535","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623309535?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:16","pubTimestamp":1774970189,"startTime":"0","endTime":"0","summary":"If you are wondering whether Elevance Health's current share price reflects its true worth, this article will walk you through what the numbers actually say.\nRecently, the stock has retreated, with returns of a 1.5% decline over 7 days, an 11.0% decline over 30 days, a 19.6% decline year to date, and a 33.1% decline over the past year from a last close of US$284.79.\nThese moves have arrived alongside ongoing sector attention on large managed care names and investor focus on how insurers are...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/is-it-time-to-reassess-elevance-health-elv-after-a-33-oneyea","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/is-it-time-to-reassess-elevance-health-elv-after-a-33-oneyea","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0048573561.USD","LU2592432038.USD","LU0648001328.SGD","ELV","LU0345770993.USD","SG9999001077.SGD","LU1983299246.USD","LU0882574055.USD","LU0122379950.USD","LU0640476718.USD","LU0234570918.USD","LU2430703251.USD","LU0878866978.SGD","LU1670628061.USD","LU0114720955.EUR","LU0006306889.USD","BK7095","ELV.AU","LU2505996681.GBP","LU1489326972.SGD","LU1720051017.SGD","SG9999004303.SGD","LU0742534661.SGD","LU1548497426.USD","LU0320765489.SGD","LU0557290698.USD","LU2237957902.USD","LU2362541273.HKD","LU2237957811.SGD","LU0208291251.USD","LU0130102774.USD","LU1280957306.USD","LU0211331839.USD","LU2505996509.AUD","DCF","LU1720051108.HKD","LU0433182093.SGD","LU1057294990.SGD","LU2244417387.USD","LU0251131958.USD","BK4585","LU0061474960.USD","LU0187121727.USD","LU2108987350.USD","LU0070302665.USD","SG9999003800.SGD","SG9999011175.SGD","BK4588","LU2362541513.USD","LU0225283273.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623320904","title":"Morella Completes Reverse Circulation Drilling at Western Australia Rubidium-Lithium Project; Shares Jump 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623320904","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623320904?lang=en_us&edition=fundamental","pubTime":"2026-03-31 07:56","pubTimestamp":1774914996,"startTime":"0","endTime":"0","summary":"Morella  completed a reverse circulation drilling program at the Mt Edon rubidium-lithium project in Western Australia, with 20 holes drilled for around 1,700 meters, according to a Tuesday Australian bourse filing.The drilling was part of Morella's joint venture strategy with Elevra Lithium .Geological logging confirmed widespread pegmatite development across the Sophie prospect, with intercepts including 84 meters of pegmatite from 18 meters as well as 53 meters of pegmatite from three meters. 11 drill holes returned pegmatite intercepts exceeding 30 meters.Shares of Morella jumped 7% in early trading on Tuesday, while those of Elevra fell 2%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LIT","WRN","XAO.AU","BK4585","XKO.AU","BK4588","ELV.AU","BK7095","1MC.AU","XJO.AU","BK4168","BK7504"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":6,"totalSize":131,"code":"91000000","status":"200"}]}}